Sverre E Kjeldsen is an expert in Cardiology at Oslo University Hospital (Norway). As of October 2026, ScienceLeadR ranks Sverre E Kjeldsen in the top 1% of experts worldwide for Essential Hypertension, Hypertension and Cardiomegaly. Sverre E Kjeldsen has authored 924 publications, the most recent in 2026, and is an investigator in 13 clinical trials. SLR score: 2,376 (community average: 125). How the SLR is computed.

LeadR Profile

Sverre E Kjeldsen Oslo University Hospital Norway
2 376 ScienceLeadR Reputation 2376
Network Map

Cardiology

Subspecialties: Hematology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1984 - 2026

Source: PubMed

Oslo University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 924

Citations

Citations: 100 575 1st author: 210 Last author: 122 Unique author: 18


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Blood pressure and cardiovascular protection in chronic kidney disease: Things are moving in nephrology!
PMID 42678176 — kidney diseases, hypertension, blood, blood pressure, kidney, nephrology
Blood Press20260
Blood pressure control and outcomes in heart failure patients with preserved ejection fraction: an individual participant data meta-analysis of four major trials.
PMID 42669130 — blood, heart failure, heart, blood pressure
Eur J Heart Fail20260
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.
PMID 42035778 — diabetes mellitus, kidney diseases, proteinuria, creatinine, blood, heart failure, pharmaceutical preparations, heart, cardiovascular diseases, blood pressure, kidney, risk management, antihypertensive agents, therapeutics
Lancet Top journal20260
Evolocumab for Primary Prevention of Cardiovascular Disease.
PMID 42019027 — cardiovascular diseases, primary prevention
N Engl J Med Top journal20260
Blood Pressure and Cardiovascular Risk in a Contemporary Cohort of Young Adults.
PMID 41883101 — hypertension, blood, cardiovascular diseases, blood pressure, respect, sex
Am J Hypertens20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1 Study Director: 2

By phase:

N/A 5
Phase 3 5
Phase 2 2
Phase 4 1

By status:

Completed 9
Unknown 2
Active not recruiting 1
Terminated 1

By type:

Interventional 11
Observational 2

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 1
multicentric5to9 2
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map